<VariationArchive RecordType="classified" VariationID="1685856" VariationName="NM_000516.7(GNAS):c.602dup (p.Val202fs)" VariationType="Duplication" Accession="VCV001685856" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2022-05-28" MostRecentSubmission="2022-05-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1677869" VariationID="1685856">
      <GeneList>
        <Gene Symbol="GNAS" FullName="GNAS complex locus" GeneID="2778" HGNC_ID="HGNC:4392" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>20q13.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="58839748" stop="58911192" display_start="58839748" display_stop="58911192" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="57414794" stop="57486249" display_start="57414794" display_stop="57486249" Strand="+" />
          </Location>
          <OMIM>139320</OMIM>
          <Haploinsufficiency last_evaluated="2021-01-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GNAS">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-01-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GNAS">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000516.7(GNAS):c.602dup (p.Val202fs)</Name>
      <CanonicalSPDI>NC_000020.11:58909365:G:GG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>20q13.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="58909365" stop="58909366" display_start="58909365" display_stop="58909366" variantLength="1" positionVCF="58909365" referenceAlleleVCF="C" alternateAlleleVCF="CG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="57484420" stop="57484421" display_start="57484420" display_stop="57484421" variantLength="1" positionVCF="57484420" referenceAlleleVCF="C" alternateAlleleVCF="CG" />
      </Location>
      <ProteinChange>V143fs</ProteinChange>
      <ProteinChange>V187fs</ProteinChange>
      <ProteinChange>V188fs</ProteinChange>
      <ProteinChange>V202fs</ProteinChange>
      <ProteinChange>V203fs</ProteinChange>
      <ProteinChange>V845fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.10" sequenceAccession="NC_000020" sequenceVersion="10" change="g.57484421dup" Assembly="GRCh37">
            <Expression>NC_000020.10:g.57484421dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.11" sequenceAccession="NC_000020" sequenceVersion="11" change="g.58909366dup" Assembly="GRCh38">
            <Expression>NC_000020.11:g.58909366dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016194.2" sequenceAccession="NG_016194" sequenceVersion="2" change="g.74627dup">
            <Expression>NG_016194.2:g.74627dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000516.7" sequenceAccession="NM_000516" sequenceVersion="7" change="c.602dup" MANESelect="true">
            <Expression>NM_000516.7:c.602dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000507.1" sequenceAccession="NP_000507" sequenceVersion="1" change="p.Val202fs">
            <Expression>NP_000507.1:p.Val202fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001077488.5" sequenceAccession="NM_001077488" sequenceVersion="5" change="c.605dup">
            <Expression>NM_001077488.5:c.605dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001070956.1" sequenceAccession="NP_001070956" sequenceVersion="1" change="p.Val203fs">
            <Expression>NP_001070956.1:p.Val203fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001077489.4" sequenceAccession="NM_001077489" sequenceVersion="4" change="c.557dup">
            <Expression>NM_001077489.4:c.557dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001070957.1" sequenceAccession="NP_001070957" sequenceVersion="1" change="p.Val187fs">
            <Expression>NP_001070957.1:p.Val187fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001077490.3" sequenceAccession="NM_001077490" sequenceVersion="3" change="c.*463dup">
            <Expression>NM_001077490.3:c.*463dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001309840.2" sequenceAccession="NM_001309840" sequenceVersion="2" change="c.425dup">
            <Expression>NM_001309840.2:c.425dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001296769.1" sequenceAccession="NP_001296769" sequenceVersion="1" change="p.Val143fs">
            <Expression>NP_001296769.1:p.Val143fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001309861.2" sequenceAccession="NM_001309861" sequenceVersion="2" change="c.425dup">
            <Expression>NM_001309861.2:c.425dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001296790.1" sequenceAccession="NP_001296790" sequenceVersion="1" change="p.Val143fs">
            <Expression>NP_001296790.1:p.Val143fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_016592.5" sequenceAccession="NM_016592" sequenceVersion="5" change="c.*508dup" MANEPlusClinical="true">
            <Expression>NM_016592.5:c.*508dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_080425.4" sequenceAccession="NM_080425" sequenceVersion="4" change="c.2531dup" MANEPlusClinical="true">
            <Expression>NM_080425.4:c.2531dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_536350.2" sequenceAccession="NP_536350" sequenceVersion="2" change="p.Val845fs">
            <Expression>NP_536350.2:p.Val845fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_080426.4" sequenceAccession="NM_080426" sequenceVersion="4" change="c.560dup">
            <Expression>NM_080426.4:c.560dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_536351.1" sequenceAccession="NP_536351" sequenceVersion="1" change="p.Val188fs">
            <Expression>NP_536351.1:p.Val188fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2146270735" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000516.7(GNAS):c.602dup (p.Val202fs) AND Pseudohypoparathyroidism type I A" Accession="RCV002250023" Version="1">
        <ClassifiedConditionList TraitSetID="66069">
          <ClassifiedCondition DB="MedGen" ID="C3494506">Pseudohypoparathyroidism type I A</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-05-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-05-04" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-05-28" MostRecentSubmission="2022-05-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="66069" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="56041" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Pseudohypoparathyroidism Type IA</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Albright hereditary osteodystrophy with multiple hormone resistance</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Pseudohypoparathyroidism type I A</ElementValue>
                <XRef ID="58833000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PHP IA</ElementValue>
                <XRef Type="MIM" ID="103580" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pseudohypoparathyroidism type 1A</ElementValue>
                <XRef ID="Pseudohypoparathyroidism+type+1A/6035" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007078" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PHP1A</ElementValue>
                <XRef Type="MIM" ID="103580" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7486" />
                <XRef ID="7486" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Disorders of GNAS inactivation include the phenotypes pseudohypoparathyroidism Ia, Ib, and Ic (PHP-Ia, -Ib, -Ic), pseudopseudohypoparathyroidism (PPHP), progressive osseous heteroplasia (POH), and osteoma cutis (OC). PHP-Ia and PHP-Ic are characterized by: End-organ resistance to endocrine hormones including parathyroid hormone (PTH), thyroid-stimulating hormone (TSH), gonadotropins (LH and FSH), growth hormone-releasing hormone (GHRH), and CNS neurotransmitters (leading to obesity and variable degrees of intellectual disability and developmental delay); and The Albright hereditary osteodystrophy (AHO) phenotype (short stature, round facies, and subcutaneous ossifications) and brachydactyly type E (shortening mainly of the 4th and/or 5th metacarpals and metatarsals and distal phalanx of the thumb). Although PHP-Ib is characterized principally by PTH resistance, some individuals also have partial TSH resistance and mild features of AHO (e.g., brachydactyly). PPHP, a more limited form of PHP-Ia, is characterized by various manifestations of the AHO phenotype without the hormone resistance or obesity. POH and OC are even more restricted variants of PPHP: POH consists of dermal ossification beginning in infancy, followed by increasing and extensive bone formation in deep muscle and fascia. OC consists of extra-skeletal ossification that is limited to the dermis and subcutaneous tissues.</Attribute>
                <XRef ID="NBK459117" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29072892</ID>
                <ID Source="BookShelf">NBK459117</ID>
              </Citation>
              <XRef ID="79443" DB="Orphanet" />
              <XRef ID="C3494506" DB="MedGen" />
              <XRef ID="MONDO:0007078" DB="MONDO" />
              <XRef Type="MIM" ID="103580" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4933188" SubmissionDate="2022-05-21" DateLastUpdated="2022-05-28" DateCreated="2022-05-28">
        <ClinVarSubmissionID localKey="NC_000020.11:g.58909365_58909366insG|OMIM:103580" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002516500" DateUpdated="2022-05-28" DateCreated="2022-05-28" Type="SCV" Version="1" SubmitterName="Mendelics" OrgID="500035" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Mendelics Assertion Criteria 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fxi2k7be/mendelics_assertion_criteria_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GNAS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000020.11:g.58909365_58909366insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="103580" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MENDELICS_CLINVAR_033</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4933188" TraitType="Disease" MappingType="XRef" MappingValue="103580" MappingRef="OMIM">
        <MedGen CUI="C3494506" Name="Pseudohypoparathyroidism type I A" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

